Transfer of Follow-up Care to Family Physicians for Early-stage Breast Cancer

Clinical Oncology

Volumn 19, Issue 3, 2007, Pages 172-176

  Vanhuyse, M ^a   Bedard, P L ^b   Sheiner, J ^b   Fitzgerald, B ^b   Clemons, M ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Breast cancer; family physician; follow up

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; TAMOXIFEN; TRASTUZUMAB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY CANCER; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PRIORITY JOURNAL; RECURRENT CANCER; SYMPTOMATOLOGY; TREATMENT REFUSAL; WORKLOAD;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CANCER CARE FACILITIES; CONTINUITY OF PATIENT CARE; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; LONG-TERM CARE; MEDICAL ONCOLOGY; MIDDLE AGED; PATIENT DISCHARGE; PHYSICIANS, FAMILY; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION;

EID: 33847103828     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.01.115     Document Type: Article

References (27)

1. Nowak A.K., Wilcken N.R., Stockler M.R., et al. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. Lancet Oncol 5 (2004) 372-380
2. Mouridsen H.T., and Robert N.J. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women. Eur J Cancer 41 (2005) 1678-1689
3. Piccart-Gebhart M.J., Proctor M., Leyland-Jones B., et al., Herceptin Adjuvant (HERA) Trial Study Team. Transtuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 (2005) 1659-1672
4. Canadian Cancer Society and National Cancer Institute of Canada. Canadian Cancer Statistics 2005, Toronto, Canada (http://www.cancer.ca/ccs/internet/standard/0,3182,3172_14291__langId-fr ,00.html).
5. Grunfeld E., Dhesy-Thind S., Levine M., and Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 172 (2005) 1319-1320
6. Cancer Care Ontario. Advance practice roles maximize health care resources and enhance access to cancer services. Ontario Cancer News 4 (May 2006) 4. http://www.cancercare.on.ca/OntarioCancerNewsArchives/200605/index_552.h tm
7. Grunfeld E., Mant D., Yudkin P., et al. Routine follow up of breast cancer in primary care: randomised trial. Br Med J 313 (1996) 665-669
8. Grunfeld E., Fitzpatrick R., Mant D., et al. Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49 (1999) 705-710
9. Grunfeld E., Gray A., Mant D., et al. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br Med J 79 (1999) 1227-1233
10. Koinberg I.L., Fridlund B., Engholm G.B., et al. Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. Eur J Oncol Nurs 8 (2004) 109-117
11. Baildam AD, Keeling F, Thompson L, et al. Nurse-led surgical follow up clinics for women treated for breast cancer - a randomised controlled trial. San Antonio Breast Cancer Symposium 2004. Abstract 3071.
12. Grunfeld E., Levine M.N., Julian J.A., et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24 (2006) 848-855
13. Coombes R.C., Hall E., Gibson L.J., et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350 (2004) 1081-1092 2004;351:2461
14. Goss PE. NCIC CTG MA.17 - final analysis of updated data - a placebo-controlled trial of letrozole following tamoxifen as adjuvant therapy in postmenopausal women with early stage breast cancer. Oral presentation at the Fortieth Annual Meeting of the American Society of Clinical Oncology, New Orleans 2004 (http://www.ctg.queensu.ca/public/asco/ma17-asco-2004.pdf).
15. The Ontario Physician Human Resources Data Centre (https://www.ophrdc.org/).
16. Grunfeld E., Whelan T.J., Zitzelsberger L., et al. Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction. CMAJ 163 (2000) 166-169
17. Grunfeld E., Zitzelsberger L., Coristine M., et al. Job stress and job satisfaction of cancer care workers. Psycho-Oncology 14 (2005) 61-69
18. Warner E., and Weinroth J. Family physician versus specialist care for breast cancer follow-up. J Clin Oncol 24 (2006) 3710a
19. Hensley M.L., Dowell J., Herndon II J.E., et al. Economic outcomes of breast cancer survivorship: CALGB study 79804. Breast Cancer Res Treat 91 (2005) 153-161
20. Khatcheressian J.L., and Smith T.J. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24 (2006) 835-837
21. College of Physicians and Surgeons of Ontario. 2005 Survey of Ontario's Physicians: Implications for the Future (http://www.cpso.on.ca/Whats_New/2005%20Physician%20Survey%20Report.pdf) .
22. Canadian Cancer Society. Ontario Cancer Statistics (http://www.cancer.ca/ccs/internet/standard/0,3182,3543_314950__langId-e n,00.html).
23. Worster A., Bass M.J., and Wood M.L. Willingness to follow breast cancer. A survey of family physicians. Can Fam Physician 42 (1996) 263-268
24. Grunfeld E., Mant D., Vessey M.P., et al. Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract 12 (1995) 60-65
25. Zitelsberger L., Grunfeld E., and Graham I.D. Family physicians' perspectives on practice guidelines related to cancer control. BMC Fam Pract 15 (2004) 25
26. Beaver K., and Luker K.A. Follow-up in breast cancer clinics: reassuring for patients rather than detecting recurrence. Psychooncology 2 (2005) 94-101
27. Ganz P.A. A teachable moment for oncologists: cancer survivors, 10 million strong and growing!. J Clin Oncol 23 (2005) 5458-5460